ERA is proud to present the ERA Long-Term Strategic Plan launched at ERA25 titled "Leading the Way in Kidney Health: Innovation, Inclusion, Impact".
ERA Guidance
About ERA Guidance
ERA actively engages in collaborations with other professional societies to develop comprehensive clinical guidelines. By combining expertise across disciplines, these partnerships ensure that recommendations are evidence-based, practical, and aligned with the latest advances in nephrology. Such joint efforts not only harmonize standards of care internationally but also foster innovation and improve patient outcomes.
Collaborate with ERA
Societies interested in co-developing guidelines with ERA are warmly encouraged to reach out and explore collaborative opportunities.
For more details or enquiries, please contact cooperation@era-online.org.
KDIGO and ERA agreement
The renewed agreement between KDIGO and ERA, signed during the 2025 ERA Congress in Vienna, reinforces the strong and ongoing collaboration between the two organizations.
This partnership continues to focus on shared goals in education, the development of clinical guidelines, and their broad dissemination. It encompasses joint initiatives such as the creation of educational programs, translation of key materials, and the publication of ERA commentaries on KDIGO guidelines in ERA journals.
The overarching aim is to enhance the implementation of clinical guidelines across the nephrology community and to promote deeper scientific collaboration between the societies.
Collaboration on guidelines
Below is a list of ERA collaborative efforts.
2026 ESE-ERA Guideline
2026 European Society for Endocrinology (ESE) and European Renal Association (ERA) Guideline on Hyponatraemia. Chaired by Mark Sherlock (ESE) and Ewout Hoorn (ERA).
2026 ESC-ERA Guidelines
2026 ESC Guidelines for the management of cardiovascular disease in chronic kidney disease [working title], developed in collaboration with the European Renal Association (ERA). Chaired by Kevin Damman and Will Herrington.
2023 ERA-ESH Guidelines
A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial Hypertension.
ERA Body Commentaries & Clinical Practice
Diabetic kidney disease (DKD)
- Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)
- SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA